Francisco Silva, VP of Research and Development at BioRestorative Therapies, Inc. (BRTX), bought 5,723 shares at $3.32 ($19K) on 2022-08-29, disclosed to the SEC on 2022-09-09.
Open-market purchase of $19k BRTX by VP of Research and Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.35 | 2,600 | $9K | 46.4% |
| 2 | $3.21 | 2,816 | $9K | 48.2% |
| 3 | $3.32 | 307 | $1K | 5.4% |
| Total | $3.28 avg | 5,723 | $19K | 100% |
| Filing → |
| BRTX | BUY | 2023-04-04 | $3K | — | Filing → |
| BRTX | BUY | 2022-11-21 | $2K | — | Filing → |
| BRTX | BUY | 2022-10-12 | $3K | — | Filing → |